Triumph Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.34K Sell
28
-11
-28% -$2.9K ﹤0.01% 1291
2026
Q2
$8.61K Buy
39
+4
+11% +$1.11K ﹤0.01% 1194
2026
Q1
$10.3K Buy
35
+5
+17% +$1.48K ﹤0.01% 1112
2025
Q4
$8.19K Buy
+30
New +$8.15K ﹤0.01% 1141

Other funds holding CME

Triumph Capital Management's CME Position: Q3 2026 in Review

Triumph Capital Management reduced its CME Group (CME) stake by 28% in Q3 2026, selling an estimated $2.9K and leaving 28 shares worth $7.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Triumph Capital Management first reported a position in CME in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.3K in Q1 2026. 1,007 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Triumph Capital Management held 28 shares of CME Group worth $7.34K as of Q3 2026.
  • Triumph Capital Management sold 11 CME Group shares in Q3 2026, an estimated $2.9K.
  • CME Group made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1291 holding.
  • Triumph Capital Management first reported a position in CME Group in Q4 2025 and has held it in 4 quarters since.
  • Triumph Capital Management's CME Group position peaked at $10.3K in Q1 2026.
  • 1,007 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.